Amarin informed by FDA that Oct. 16 advisory committee meeting will take place

Amarin announced that it was notified by the FDA that the scheduled advisory committee meeting to be held on October 16, in connection with the proposed Vascepa ANCHOR indication will take place as scheduled despite the current Federal Government lapse in appropriations.

Advertisement